Atrás
Precio Enlivex Therapeutics Ltd (ENLV)
Gráfico del Precio de Acciones ENLV
ENLV Ganando
Enlivex Therapeutics Ltd
$0.94
0.66%
$0
Al cierre: Jan 16, 16:00:00 GMT-5
$0.93
-0.71%
$0
Mercado Posterior: Jan 16, 20:00:00 GMT-5
Estadísticas clave
Cierre Anterior
$0.9338
Precio de apertura
$0.97
Rango del día
$0.9331 - $0.9863
Rango de 52 semanas
$0.66 - $2.1
Volumen
379.2K
Volumen promedio
3.9M
EPS (TTM)
-0.55
Rendimiento de dividendos
--
Cap. de mercado
$220.5M
¿Qué es ENLV?
Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved